MIAMI, FL, Oct. 31, 2025 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory…
RADNOR, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor…
Alps ordinary shares to list on the Nasdaq under the symbol “ALPS” on October 31, 2025 KUALA LUMPUR, Malaysia and NEWARK, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) — Alps Group…
NEW YORK and VIENNA, Oct. 31, 2025 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (OTCID: HOOK, “HOOKIPA”) today announced the completion of the sale of its assets related to HOOKIPA’s HB-400…
COPENHAGEN, Denmark, October 31, 2025 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its third…
, /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences: UBS Global Healthcare Conference 2025 Tuesday, Nov. 11 at 3:30 p.m.…
, /PRNewswire/ — Intensity Therapeutics, Inc. (Nasdaq: INTS) (“Intensity” or the “Company”), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are…
, /PRNewswire/ — Servier today announced that VORANIGO® (vorasidenib) has been awarded The Galien Foundation’s 2025 Prix Galien USA Award for Best Product for Orphan/Rare Disease. The award was presented…
, /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA) today announced that the company has extended its multi-year strategic partnership with Bayer to advance research and development of biological products for agriculture.…
– Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naïve patients with differentiated thyroid cancer – , /PRNewswire/ — Alpha Fusion Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO:…